Avalyn Pharma appoints Robert Meyer to board
Avalyn Pharma appointed Robert Meyer, M.D. to its board as a Class II director, effective September 15, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.